Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Oparil

Showing results (271-280 of 288) with videos related to

Pageof 29
Sort By:
The American Journal of Cardiology|September 25, 1999
Effects of candesartan cilexetil in patients with severe systemic hypertension. Candesartan Cilexetil Study InvestigatorsS Oparil, J H Levine, C A Zuschke, et al.
The American Journal of Physiology|August 1, 1997
Volume-overload cardiac hypertrophy is unaffected by ACE inhibitor treatment in dogsL J Dell'italia, E Balcells, Q C Meng, et al.
The American Journal of Physiology|November 14, 1997
Hypoxia stimulates human preproendothelin-1 promoter activity in transgenic miceC R Aversa, S Oparil, J Caro, et al.
American Journal of Hypertension|August 19, 2000
Lowering of blood pressure and predictors of response in patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For EndpointS E Kjeldsen, B Dahlöf, R B Devereux, et al.
American Journal of Hypertension|July 1, 1997
The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study GroupB Dahlöf, R Devereux, U de Faire, et al.
American Journal of Hypertension|September 12, 2000
Factors affecting blood pressure responses to diet: the Vanguard studyL M Resnick, S Oparil, A Chait, et al.
The American Journal of Clinical Nutrition|December 1, 1996
Improved quality of life in patients with generalized cardiovascular metabolic disease on a prepared dietD C Hatton, R B Haynes, S Oparil, et al.
Hypertension (Dallas, Tex. : 1979)|December 18, 1998
Characteristics of 9194 patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint Reduction in HypertensionB Dahlöf, R B Devereux, S Julius, et al.
Journal of the American Dietetic Association|September 24, 1999
Nutritionally complete prepared meal plan to reduce cardiovascular risk factors: a randomized clinical trialR B Haynes, P Kris-Etherton, D A McCarron, et al.
Archives of Internal Medicine|January 27, 1997
Nutritional management of cardiovascular risk factors. A randomized clinical trialD A McCarron, S Oparil, A Chait, et al.
Pageof 29

Showing results (271-280 of 288) with videos related to

Sort By:
Pageof 29
The American Journal of Cardiology|September 25, 1999
Effects of candesartan cilexetil in patients with severe systemic hypertension. Candesartan Cilexetil Study InvestigatorsS Oparil, J H Levine, C A Zuschke, et al.
The American Journal of Physiology|August 1, 1997
Volume-overload cardiac hypertrophy is unaffected by ACE inhibitor treatment in dogsL J Dell'italia, E Balcells, Q C Meng, et al.
The American Journal of Physiology|November 14, 1997
Hypoxia stimulates human preproendothelin-1 promoter activity in transgenic miceC R Aversa, S Oparil, J Caro, et al.
American Journal of Hypertension|August 19, 2000
Lowering of blood pressure and predictors of response in patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For EndpointS E Kjeldsen, B Dahlöf, R B Devereux, et al.
American Journal of Hypertension|July 1, 1997
The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study GroupB Dahlöf, R Devereux, U de Faire, et al.
American Journal of Hypertension|September 12, 2000
Factors affecting blood pressure responses to diet: the Vanguard studyL M Resnick, S Oparil, A Chait, et al.
The American Journal of Clinical Nutrition|December 1, 1996
Improved quality of life in patients with generalized cardiovascular metabolic disease on a prepared dietD C Hatton, R B Haynes, S Oparil, et al.
Hypertension (Dallas, Tex. : 1979)|December 18, 1998
Characteristics of 9194 patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint Reduction in HypertensionB Dahlöf, R B Devereux, S Julius, et al.
Journal of the American Dietetic Association|September 24, 1999
Nutritionally complete prepared meal plan to reduce cardiovascular risk factors: a randomized clinical trialR B Haynes, P Kris-Etherton, D A McCarron, et al.
Archives of Internal Medicine|January 27, 1997
Nutritional management of cardiovascular risk factors. A randomized clinical trialD A McCarron, S Oparil, A Chait, et al.
Pageof 29